Benjamin R. Yerxa's most recent trade in Opus Genetics Inc. was a trade of 400,000 Common Stock done . Disclosure was reported to the exchange on Jan. 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc | Benjamin R. Yerxa | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 400,000 | 719,005 | - | 0 | Common Stock | |
| Opus Genetics Inc | Benjamin R. Yerxa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.95 per share. | 22 Oct 2025 | 23,795 | 319,005 | - | 1.9 | 46,400 | Common Stock |
| Opus Genetics Inc | Benjamin R. Yerxa | Director, President | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 21 Nov 2024 | 10,000 | 342,800 | - | 1.0 | 9,834 | Common Stock |
| Opus Genetics Inc | Benjamin R. Yerxa | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 332,800 | 332,800 | - | 0 | Common Stock | |
| Clearside Biomedical Inc | Benjamin R. Yerxa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Clearside Biomedical Inc | Benjamin R. Yerxa | Director | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 15 May 2024 | 7,813 | 17,957 (0%) | 0% | 1.3 | 10,235 | Common Stock |
| Clearside Biomedical Inc | Benjamin R. Yerxa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Clearside Biomedical Inc | Benjamin R. Yerxa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |